ID: ALA5271759

Max Phase: Preclinical

Molecular Formula: C19H30O2

Molecular Weight: 290.45

Associated Items:

Representations

Canonical SMILES:  CCCCC(CC)COC(=O)c1ccc(C(C)(C)C)cc1

Standard InChI:  InChI=1S/C19H30O2/c1-6-8-9-15(7-2)14-21-18(20)16-10-12-17(13-11-16)19(3,4)5/h10-13,15H,6-9,14H2,1-5H3

Standard InChI Key:  SBTSOUSSYNGQHT-UHFFFAOYSA-N

Associated Targets(non-human)

Trypanosoma cruzi 99888 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 290.45Molecular Weight (Monoisotopic): 290.2246AlogP: 5.36#Rotatable Bonds: 7
Polar Surface Area: 26.30Molecular Species: HBA: 2HBD: 0
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 6.54CX LogD: 6.54
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.63Np Likeness Score: -0.17

References

1. Leão LPMO, de B Vieira N, Oliveira PPS, Chagas-Paula DA, Soares MG, Souza TB, Baldim JL, Costa-Silva TA, Tempone AG, Dias DF, Lago JHG..  (2023)  Structure-activity relationship study of antitrypanosomal analogues of gibbilimbol B using multivariate analysis and computation-aided drug design.,  83  [PMID:36805048] [10.1016/j.bmcl.2023.129190]

Source